Common Stock Warrants – Page 44

Hut 8 Finalizes Terms of $7.5 Million Overnight Marketed Public Offering of Units – Canada NewsWire

Hut 8 Finalizes Terms of $7.5 Million Overnight Marketed Public Offering of Units Canada NewsWire … Continue reading →

Hut 8 Finalizes Terms of $7.5 Million Overnight Marketed Public Offering of Units – Canada NewsWire Read More »

Triumph Group, Inc. S-3 Jun. 11, 2020 4:01 PM – Seeking Alpha

Cdn Warrant News, Common Stock Warrants / https://commonstockwarrants.com

Triumph Group, Inc. S-3 Jun. 11, 2020 4:01 PM Seeking Alpha … Continue reading →

Triumph Group, Inc. S-3 Jun. 11, 2020 4:01 PM – Seeking Alpha Read More »

HUDSON EXECUTIVE INVESTMENT CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events (form 8-K) – marketscreener.com

Cdn Warrant News, Common Stock Warrants / https://commonstockwarrants.com

HUDSON EXECUTIVE INVESTMENT CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events (form 8-K) marketscreener.com … Continue reading →

Hudson Executive Investment Corp. Announces Closing of $414 Million Initial Public Offering – Stockhouse

Cdn Warrant News, Common Stock Warrants / https://commonstockwarrants.com

Hudson Executive Investment Corp. Announces Closing of $414 Million Initial Public Offering Stockhouse … Continue reading →

Hudson Executive Investment Corp. Announces Closing of $414 Million Initial Public Offering – Stockhouse Read More »

Entasis Therapeutics Completes Closing of Second Tranche of $35M Private Placement with Innoviva – GlobeNewswire

Common Stock Warrants, US Warrant News / https://commonstockwarrants.com

Entasis Therapeutics Completes Closing of Second Tranche of $35M Private Placement with Innoviva GlobeNewswire … Continue reading →

Entasis Therapeutics Completes Closing of Second Tranche of $35M Private Placement with Innoviva – GlobeNewswire Read More »

Scopus BioPharma Licenses Novel Immuno-Oncology Gene Therapy Drug from City of Hope, a Cancer Center in Los Angeles, California – cnweekly

Common Stock Warrants, US Warrant News / https://commonstockwarrants.com

Scopus BioPharma Licenses Novel Immuno-Oncology Gene Therapy Drug from City of Hope, a Cancer Center in Los Angeles, California cnweekly … Continue reading →

Scopus BioPharma Licenses Novel Immuno-Oncology Gene Therapy Drug from City of Hope, a Cancer Center in Los Angeles, California – cnweekly Read More »